AAAAAA
Results:
1-8
|
Results: 8
Authors:
Chamberland, S
Blais, J
Hoang, M
Dinh, C
Cotter, D
Bond, E
Gannon, C
Park, C
Malouin, F
Dudley, MN
Citation: S. Chamberland et al., In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria, ANTIM AG CH, 45(5), 2001, pp. 1422-1430
Authors:
Livermore, DM
Dudley, MN
Citation: Dm. Livermore et Mn. Dudley, Antimicrobials: better use, better drugs, or both? Editorial overview, CURR OPIN M, 3(5), 2000, pp. 487-488
Authors:
Dudley, MN
Ambrose, PG
Citation: Mn. Dudley et Pg. Ambrose, Pharmacodynamics in the study of drug resistance and establishing in vitrosusceptibility breakpoints: ready for prime time, CURR OPIN M, 3(5), 2000, pp. 515-521
Authors:
Jackson, KA
Rosenbaum, SE
Kerr, BM
Pithavala, YK
Yuen, G
Dudley, MN
Citation: Ka. Jackson et al., A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial, ANTIM AG CH, 44(7), 2000, pp. 1832-1837
Authors:
Glinka, TW
Cho, A
Zhang, ZJ
Ludwikow, M
Griffith, D
Huie, K
Hecker, SJ
Dudley, MN
Lee, VJ
Chamberland, S
Citation: Tw. Glinka et al., SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems, J ANTIBIOT, 53(10), 2000, pp. 1045-1052
Authors:
Rana, KZ
Dudley, MN
Citation: Kz. Rana et Mn. Dudley, Intracellular phosphorylation of zidovudine in an in vitro hollow fiber model, PHARMACOTHE, 19(8), 1999, pp. 979-983
Authors:
Rana, KZ
Dudley, MN
Citation: Kz. Rana et Mn. Dudley, Human immunodeficiency virus protease inhibitors, PHARMACOTHE, 19(1), 1999, pp. 35-59
Authors:
Rana, KZ
Simmons, KA
Dudley, MN
Citation: Kz. Rana et al., Hydroxyurea reduces the 50% inhibitory concentration of didanosine in HIV-infected cells, AIDS, 13(15), 1999, pp. 2186-2188
Risultati:
1-8
|